AstraZeneca and Sanofi gets European Approval for Drugs Preventing RSV for Infants

The European Commission (EC) approved Beyfortus, jointly developed by AstraZeneca and Sanofi, for the prevention of a common and highly contagious type of respiratory infection in infants. This long-acting therapy, which is also known as nirsevimab, was given marketing authorisation in the European Union (EU) for the prevention of disease from several infections caused by […]

Continue Reading